Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997

J Hum Virol. 2000 May-Jun;3(3):157-64.

Abstract

Objective: Few studies have been able to track the genetic diversity of HIV-1 viruses in human populations over time. We analyzed the molecular evolution of subtype A over a 10-year period, in a cohort of female sex workers with a known time of infection.

Study design/methods: We amplified and sequenced the C2-V3 region of the surface envelope glycoprotein from 73 HIV-1-infected women, infected between 1987-1997.

Results: Fifty-one patients were infected by subtype A viruses. The viruses demonstrated significant diversification (p < 0.001) with mean genetic distance increasing from 8.6% in 1989 to 15.9% in 1997. The slope of the fitted curve suggested a rate of diversification of 0.7% per year. The majority of subtype A viruses clustered with HIV-1 subtype A/G recombinant form (IbNG).

Conclusion: The genetic diversity of HIV-1 subtype A infections doubled over the first 10 years of this high risk population's epidemic, suggesting that implementation of vaccines early in the epidemic may have a higher likelihood of success based on levels of genetic diversity. The A/G recombinant form (IbNG) has taken epidemic proportions in West Africa. This is of particular importance in understanding the epidemiology of HIV-1 subtypes in Africa and to further dissect the potential phenotypic and biological characteristics of these viruses.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cohort Studies
  • DNA, Viral / analysis
  • Evolution, Molecular
  • Female
  • Gene Products, gag / genetics
  • Genetic Variation
  • HIV Infections / epidemiology
  • HIV Infections / virology*
  • HIV-1 / chemistry
  • HIV-1 / classification
  • HIV-1 / genetics*
  • Humans
  • Phylogeny
  • RNA, Viral / genetics
  • Senegal / epidemiology
  • Sex Work
  • Viral Envelope Proteins / genetics

Substances

  • DNA, Viral
  • Gene Products, gag
  • RNA, Viral
  • Viral Envelope Proteins